Has David Ilo, MD received payments from drug or device companies?

Yes. Drug and device makers reported $85,759 in general payments to David Ilo, MD across 50 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean David Ilo, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about David Ilo, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

David Ilo, MD

Internal Medicine · Fort Wayne, INNPI 1104094689

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $85,695 of the $85,759 with a category attached, or 99.9%. CSL Plasma Inc. accounts for 99.9% of it on its own, with 3 other manufacturers making up the rest. 2025 is the largest year on record at $62,025, more than ten times the $15 reported in 2022. Among internal medicine clinicians in IN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$85,759in general payments, 2019–2025

Across 50 payments — averaging $1715.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

CSL Plasma Inc.$86K
Teva Pharmaceuticals USA, Inc.$32
Acadia Pharmaceuticals Inc$17
Lilly USA, LLC$15

What the payments were for

Consulting fees$85,695100%
Food & beverage$640%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
CSL Plasma Inc.	46	$85,695
Teva Pharmaceuticals USA, Inc.	2	$32
Acadia Pharmaceuticals Inc	1	$17
Lilly USA, LLC	1	$15

How this compares

$85,759 in reported general payments places this provider in the 95th percentile of 1,747 internal medicine providers in Indiana.

See all internal medicine providers in Indiana →

Medicare billing

Part B allowed, 2024

$124,972

Medicare patients

202

Services billed

1,452

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
EliquisApixaban	432	$138,784
TrulicityDulaglutide	151	$133,694
MounjaroTirzepatide	65	$57,181
XareltoRivaroxaban	177	$55,176
JardianceEmpagliflozin	139	$42,606
Risperdal ConstaRisperidone Microspheres	44	$35,406
OzempicSemaglutide	30	$30,767
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog	183	$30,573
TradjentaLinagliptin	95	$28,150
Combivent RespimatIpratropium/Albuterol Sulfate	51	$26,192
NuedextaDextromethorphan Hbr/Quinidine	42	$24,445
EntrestoSacubitril/Valsartan	55	$19,992
ShingrixVaricella-Zoster Ge/As01b/Pf	90	$19,234
JanuviaSitagliptin Phosphate	39	$15,496
Breo ElliptaFluticasone/Vilanterol	34	$14,672

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

Company	Paid to this provider	Part D cost of their drugs
Lilly USA, LLCTrulicity, Mounjaro	$15	$190,876216 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,747 internal medicine providers in Indiana.

Other internal medicine in Fort Wayne

Anuradha KolliparaFort Wayne$30K
Sumona KabirFort Wayne$28K
Abhinav SinghGreenwood$733K
Girish KunapareddyTerre Haute$329K
Raj VuppalanchiIndianapolis$279K
Joseph Arulandula Porte$251K
Napoleon MamintaIndianapolis$116K
Jennifer PaisleyLawrenceburg$112K
Allon FriedmanIndianapolis$111K
John AyresIndianapolis$107K

See the full list for Indiana →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →